These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 9043475

  • 1. Changing patterns and surgical results in adenocarcinoma of the oesophagus.
    Thomas P, Doddoli C, Lienne P, Morati N, Thirion X, Garbe L, Giudicelli R, Fuentes P.
    Br J Surg; 1997 Jan; 84(1):119-25. PubMed ID: 9043475
    [Abstract] [Full Text] [Related]

  • 2. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction.
    Zhang X, Watson DI, Jamieson GG, Lally C, Bessell JR, Devitt PG.
    ANZ J Surg; 2005 Jul; 75(7):513-9. PubMed ID: 15972033
    [Abstract] [Full Text] [Related]

  • 3. Early adenocarcinoma in Barrett's oesophagus.
    Hölscher AH, Bollschweiler E, Schneider PM, Siewert JR.
    Br J Surg; 1997 Oct; 84(10):1470-3. PubMed ID: 9361616
    [Abstract] [Full Text] [Related]

  • 4. Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer.
    Fountoulakis A, Zafirellis KD, Dolan K, Dexter SP, Martin IG, Sue-Ling HM.
    Br J Surg; 2004 Aug; 91(8):997-1003. PubMed ID: 15286961
    [Abstract] [Full Text] [Related]

  • 5. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
    Incarbone R, Bonavina L, Bassi F, Peracchia A.
    Chir Ital; 2002 Aug; 54(5):591-6. PubMed ID: 12469454
    [Abstract] [Full Text] [Related]

  • 6. Oesophagectomy for tumours and dysplasia of the oesophagus and gastro-oesophageal junction.
    Epari K, Cade R.
    ANZ J Surg; 2009 Apr; 79(4):251-7. PubMed ID: 19432710
    [Abstract] [Full Text] [Related]

  • 7. Exclusive radical surgery for esophageal adenocarcinoma.
    Collard JM.
    Cancer; 2001 Mar 15; 91(6):1098-104. PubMed ID: 11267954
    [Abstract] [Full Text] [Related]

  • 8. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
    Han JQ, Liu Q, Liang RX, Qu FS, Yan TX, Sun YH, Li XQ.
    Zhonghua Zhong Liu Za Zhi; 2007 Jun 15; 29(6):470-3. PubMed ID: 17974287
    [Abstract] [Full Text] [Related]

  • 9. Pathologic prognostic factors in Barrett's associated adenocarcinoma: a follow-up study of 96 patients.
    Torres C, Turner JR, Wang HH, Richards W, Sugarbaker D, Shahsafaei A, Odze RD.
    Cancer; 1999 Feb 01; 85(3):520-8. PubMed ID: 10091725
    [Abstract] [Full Text] [Related]

  • 10. Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis.
    Pohl H, Sonnenberg A, Strobel S, Eckardt A, Rösch T.
    Gastrointest Endosc; 2009 Oct 01; 70(4):623-31. PubMed ID: 19394011
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
    Quera R, O'Sullivan K, Quigley EM.
    Endoscopy; 2006 Feb 01; 38(2):162-9. PubMed ID: 16479424
    [Abstract] [Full Text] [Related]

  • 13. Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus.
    Sujendran V, Sica G, Warren B, Maynard N.
    Eur J Cardiothorac Surg; 2005 Nov 01; 28(5):763-6. PubMed ID: 16188449
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A, Lightdale CJ, Ross AS, Fedi P, Hart J, Rotterdam H, Noffsinger A, Memeo L, Bhagat G, Waxman I.
    Endoscopy; 2007 Dec 01; 39(12):1086-91. PubMed ID: 17701854
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus.
    Incarbone R, Bonavina L, Saino G, Bona D, Peracchia A.
    Surg Endosc; 2002 Feb 01; 16(2):263-6. PubMed ID: 11967675
    [Abstract] [Full Text] [Related]

  • 17. Pathological determinants of survival in node-negative oesophageal cancer.
    Khan OA, Alexiou C, Soomro I, Duffy JP, Morgan WE, Beggs FD.
    Br J Surg; 2004 Dec 01; 91(12):1586-91. PubMed ID: 15505868
    [Abstract] [Full Text] [Related]

  • 18. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC, Port JL, Paul S, Stiles BM, Altorki NK.
    Ann Thorac Surg; 2009 Jul 01; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [Abstract] [Full Text] [Related]

  • 19. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1484-93. PubMed ID: 15590179
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.